Companies › NMRA

NEUMORA THERAPEUTICS INC. (NMRA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001885522 · EDGAR filings · Updated 2026-07-27

NEUMORA THERAPEUTICS INC. (NMRA) has reported institutional ownership of 38.7%, with 114 institutional managers holding positions valued at $137.2M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Filings this week (1)

• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-15 — Current report (8-K) filed
• 2026-05-29 — Insider transaction reported (Form 4)
• 2026-05-29 — Insider transaction reported (Form 4)
• 2026-05-29 — Insider transaction reported (Form 4)
• 2026-05-29 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NEUMORA THERAPEUTICS INC. has 114 institutional holders and institutional ownership of 38.7%.

Insider activity

Insiders reported 10 transactions (3 buys, 5 sells) across 7 reporting insiders, with a net reported value of $14.6M.

Data flags from SEC filings

Related companies

ORGANOGENESIS HLDGS INC (ORGO) · KORRO BIO INC (KRRO) · CVRX INC (CVRX) · ELEDON PHARMACEUTICALS INC (ELDN) · INFUSYSTEM HLDGS INC (INFU) · VOYAGER THERAPEUTICS INC (VYGR)